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Abstract. In recent years the usefulness of enzymatic systems to obtain a single stereoisomerically pure 
compound starting from a racemate has been expanded. Moreover, current advances in protein 
engineering, molecular biology and modeling tools are the basis to improve the catalytic properties of 
enzymes to face novel synthetic challenges. Also, medium engineering and novel immobilization 
methods of (bio)catalysts are enhancing the productivity of biocatalytic processes making them suitable 
for being scalable. The development of multienzymatic protocols and the combination of enzymes with 
other catalysts are providing a wide range of synthetic possibilities that are expanding the scope of these 
transformations even at industrial scale. Herein we will describe an overview of recent (chemo)enzymatic 
deracemizations, focusing on the strategy employed (dynamic kinetic resolution, stereoinversion, cyclic 
deracemization or enantioconvergent process), the type of substrate (e.g., alcohols, amines, carboxylic 
acid derivatives or carbonylic compounds), and the biocatalyst(s) used. 
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1. Introduction 
The concept of reaction efficiency for chemists and engineers has undergone substantial changes. While 
historically the success of a chemical process relied entirely upon the product yield, aspects such as waste 
generation and toxic properties of the chemicals used were neglected. Additionally, increasing 
environmental concerns of society arose after the publication of Anastas and Warner in 1998 about the 
principles of eco-friendly chemical processes, the so-called Green Chemistry.
[1]
 These principles 
considered safety matters associated with the manufacture, use and disposal of chemical products, and the 
efficient utilization of raw materials with minimization of waste production through implementation of 
catalytic processes. As a result, an efficient chemical process is turning into a procedure where minimal 
amounts of waste are produced while the product yield is maximized. 
In this context, biocatalytic methods are gaining more relevance as they meet several requirements such 
as excellent selectivities under mild reaction conditions.
[2]
 While traditionally the use of enzymes was 
restricted to the selective modification of racemic mixtures in kinetic resolution (KR) protocols, 
researchers realized the potential of enzymatic methodologies to afford enantiomerically pure compounds 
circumventing the maximum 50% yield inherent to KRs. In particular, the employment of enzymatic 
desymmetrizations starting from prochiral derivatives has demonstrated an enormous potential and 
obviously has still an extreme significance in many interesting asymmetric processes.
[3]
 However, 
racemates are more readily available starting materials than prochiral substrates. Thus, the development 
of other catalytic enzymatic strategies that enable access to 100% theoretical yield of stereoisomerically 
enriched compounds starting from accessible racemic mixtures, has attracted many efforts since mid-90s 
due to the simpler isolation and purification techniques required.
[4]
 Collectively, these protocols can be 
encompassed in the so-called deracemization systems. Whereas the first non-enzymatic examples can be 
ascribed to enantioselective protonations,
[5]
 in the case of enzymatic-mediated processes, the bioreduction 
of α-substituted ketones that can racemize under basic conditions are probably the first ones.[6] 
Among the different protocols to deracemize a racemic mixture (Scheme 1), dynamic kinetic resolutions, 
deracemizations via stereoinversion, cyclic deracemizations and enantioconvergent processes can be 
mentioned. This review, mainly covering the period from 2011 onwards, describes the application of 
these methods to the synthesis of enantioenriched compounds where the key step is performed by at least 
one biocatalyst. For the coverage of earlier examples the reader is referred to previous excellent reviews 
and monographs.
[7-13]
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Scheme 1. General representations of deracemization strategies. 
 
2. Dynamic kinetic resolutions (DKRs) 
DKRs are by far the most employed strategies for deracemization. This approach relies on a racemization 
step of the substrate enantiomers combined with a selective transformation over one single enantiomer 
through a kinetic resolution process (Scheme 1). Theoretically, this would afford the final (enantiopure) 
product in quantitative yield. Noyori coined these systems as DKRs when performing Ru-catalyzed 
hydrogenations of α-substituted β-keto esters.[14] Due to the intrinsic selectivities shown by enzymes 
when reacting with racemic mixtures, the combination of biocatalyzed methodologies with different 
racemization techniques has allowed the efficient development of enzymatic-based DKRs.
[15-19]
 
Among the different features that a good DKR process must accomplish, probably the most important is 
that the racemization reaction should be fast enough in order to maintain a perfect equilibration between 
both enantiomers in the racemic mixture. It must be taken into account that an inefficient rate would 
afford an increasing concentration of the non-reacting enantiomer and therefore, a loss in the selectivity 
within the time. In fact, ideally, racemization should be at least 10-times faster than the kinetic resolution. 
Reaction conditions for both processes must be compatible and should not interfere within each other, this 
is, the product formed must not racemize. One advantage of this method regarding classical KRs is that a 
reasonable selectivity (E >20), can afford the final compound with high enantiomeric excess.
[20]
 
Most of the DKR examples found in literature are related with the discrimination of racemic alcohols, 
amines, carbonylic and carboxylic acid derivatives, depending on the biocatalyst source. On the other 
hand, over racemization techniques, metal-mediated, the use of basic or acidic conditions, or the 
employment of reversible addition reactions, are the most prominent when combined with enzymes (vide 
infra). 
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2.1. DKRs over alcohol derivatives using hydrolases 
Due to the easy accessibility and readily racemization of alcohol compounds, many examples related to 
the deracemization of alcohol derivatives have recently been published. Thus, among the different ways 
to interconvert both alcohol antipodes, the use of a redox system which ensures the racemization through 
a carbonylic intermediate is probably one of the most commonly employed (Scheme 2a).
[21]
 Since 
Bäckvall’s pioneering work combining a lipase with a metal-catalyst to resolve secondary alcohols via 
enantioselective acylation,
[22]
 research has been devoted to the employment of homogeneous metal-
catalysts with hydrolases in order to undertake the resolution of valuable derivatives. The stability of 
these enzymes in organic solvents and the relatively low temperatures where these metallic complexes 
can work has greatly broadened the applicability of these systems. Considering the different metal 
catalysts, ruthenium complexes stand out as the most practical. For instance, Shvo’s catalyst (1, Scheme 
2b),
[23]
 has been recurrently chosen to achieve these transformations. Recently, Alcántara and co-workers 
have shown its use with lipase from Pseudomonas stutzeri (TL) to deracemize a series of benzoin 
derivatives in tetrahydrofuran (THF) at 50 ºC in a sequential manner.
[24]
 In a later study, the same authors 
reported that 2-methyltetrahydrofuran (2-MeTHF) was a more appropriate solvent to perform these DKRs 
in one-pot at 55 ºC.
[25]
 Bäckvall et al. also showed the application of 1 to racemize 3-substituted cyclic 
allylic alcohols in the presence of lipases from Candida antarctica type B (CAL-B) or Pseudomonas 
cepacia (PS-IM). Using this methodology, the corresponding (R)-acetates were obtained in usually high 
conversions (>60%) and ee (up to 99%).
[26] 
This DKR was performed in toluene at 60-80 ºC as the 
reversible transfer hydrogenation of alcohols/ketones generally required high temperatures. 
 
Scheme 2. a) Dynamic kinetic resolution of secondary alcohols through metal-based racemization via 
redox process. b) Examples of metal complexes used in these transformations. 
However, in the last few years, other Ru-based complexes have been studied in order to address this 
issue. Thus, (η5C5Ph5)Ru(CO)2Cl (2, Scheme 2b), discovered by Bäckvall’s group,
[27]
 has proved to be an 
excellent catalyst working with different lipases at conditions close to room temperature. Among the 
different alcohols successfully resolved (Figure 1), a β-hydroxy nitrile precursor of duloxetine,[28] N-
protected piperidin-3-ols and pirrolidin-3-ols,
[29]
 cyclic allylic alcohols,
[30]
 homoallylic alcohols,
[31]
 and 1-
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tert-butoxypropan-2-ol,
[32]
 can be mentioned. With this complex, the addition of bases such as t-BuOK 
(5% mol) and Na2CO3 (1 equiv.) is necessary in order to activate it. Other ruthenium catalysts that have 
recently been employed in dynamic protocols are derivatives 3-6 (Scheme 2b). While 3 has been 
effectively utilized in the racemization of a series of aromatic and aliphatic secondary alcohols,
[33]
 catalyst 
4 has been applied to the DKR of an aliphatic
[34]
 and an allylic
[35]
 sec-alcohol. Additionally, Ru-complex 
5 was used to synthesize enantioenriched 1,2-diarylethanols,
[36]
 and 6 has achieved excellent DKR 
protocols together with a salenol-derived ligand and TEMPO to deracemize 1-phenylethanol,
[37]
 or in 
combination with 1,4-bis(diphenylphosphino)butane as ligand in order to obtain enantioenriched benzoins 
(Figure 1).
[38]
 In all these processes, the addition of a base was also mandatory. 
 
Figure 1. Examples of secondary alcohols deracemized via DKR using Ru-based complexes 2-6 as 
racemizing agents. 
On the other hand, molecular biology tools have been used to modify biocatalysts improving their 
selectivities and/or stabilities. Thus, Bäckvall and co-workers have applied CAL-B mutants to access to a 
series of (S)-acetate products with excellent conversions and ee when combined with Ru-complex 2, 
inverting the selectivity displayed by the wild-type enzyme.
[39]
 A similar approach described by Ema et 
al. allowed the successful deracemization via DKR of several sterically hindered secondary alcohols 
using a mutant of lipase from Burkholderia (Pseudomonas) cepacia together with 2 to synthesize the 
corresponding (R)-esters in high yields (>70%) and excellent selectivities (>95%).
[40]
 A novel lipase 
preparation has also been described by Park and co-workers adding an ionic surfactant. In this case, lipase 
from B. cepacia, which is generally less active than CAL-B in these transformations, was coated with an 
ionic surfactant, showing an activity increase of even 2-3 folds against a series of aromatic alcohols. 
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Moreover, under the presence of Ru catalysts 4 and 5, the DKR processes proceeded smoothly obtaining 
the (R)-acetylated derivatives in excellent yields (>90%) and ee (>95%).
[41,42]
 
Apart from ruthenium, other transition metals have been successfully employed to achieve 
chemoenzymatic DKRs. Ikariya and co-workers reported the use of (η5C5Me5)Ir[κ
2
(N,C)-(NHCMe2-2-
C6H4), a bifunctional amidoiridium complex, combined with CAL-B in toluene at 30 ºC, obtaining the 
corresponding enantiopure (R)-acetates of several aliphatic and aromatic sec-alcohols in high yields 
(>80%).
[43]
 More recently, Akai et al. have combined the use of an oxovanadium catalyst immobilized 
inside mesoporous silica (MPS), which ensured the compartmentalization between both metal- and bio-
catalysts (CAL-B or PS-IM).
[44]
 Thus, (R)-acetylated derivatives from a series of aromatic and allylic 
alcohols were synthesized at 35 ºC using heptane or acetonitrile (MeCN) as solvents in very high 
conversions (>80%) and enantiomeric excess (>95%). Moreover, when starting from compounds bearing 
the alcohol at benzylic position (7, Scheme 3), the final (R)-acetate derivatives 8 could be attained as the 
sole products. In this case, the racemization proceeded through 1,3-transposition of the hydroxyl group. 
 
Scheme 3. DKR of allylic alcohols 7 through immobilized oxovanadium racemization giving access to 
acetates (R)-8.
[44]
 
The racemization of secondary alcohols can also be achieved in acidic conditions through the 
corresponding carbocation intermediate. Since aromatic alcohols are prone to form benzylic carbocations, 
many examples have recently been reported. To reach this goal different materials such as zeolites and 
cation-exchange resins have been employed in combination with different lipases. Thus, H-β nanozeolite 
microspheres in combination with CAL-B,
[45]
 resin Nafion SAC-13 together with CAL-B supported on 
ionic liquid-like phases under microwave conditions,
[46]
 and a nano solid super acid formed by TiO2/SO4
-2
 
combined with CAL-B,
[47]
 have successfully allowed the formation of various aromatic (R)-esters in high 
yields and ee with a minimum formation of undesired by-products. A methodology proposed by Jaenicke 
et al. was even extended to non-aromatic derivatives such as 1-cyclohexylethanol or 2-pentanol.
[48]
 In this 
case an acidic β zeolite was covered by an inert Silicalite-1 material to minimize secondary reactions such 
as product racemization or dehydration. In the presence of CAL-B in toluene at 60 ºC, the final (R)-esters 
were accessed in high conversions (>90%) and selectivities (>99%). 
An especial case has been reported by Akai and co-workers
[49]
 which deracemized nitrone 9 using CAL-B 
and acyl donor 10 in MeCN at low temperature (5-10 ºC), in order to synthesize tricyclic derivative 11 in 
a cascade protocol (Scheme 4a). This compound is an intermediate of (‒)-rosmarinecine, which is 
precursor of natural alkaloids. After a detailed study, the authors proposed as the most plausible 
mechanism for racemization of 9 the elimination of the hydroxyl group after protonation, followed by the 
conjugate addition of water to the pyrrolinium salt 12 (Scheme 4b). 
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Scheme 4. a) DKR of nitrone 9 to obtain tricyclic derivative 11 through a cascade reaction. b) Plausible 
mechanism for racemization of compound 9.
[49]
 
The use of a reversible addition reaction has been taken as an advantage to perform DKRs when the labile 
chiral intermediate obtained can be selectively (and irreversibly) transformed into the final 
enantioenriched product. Among the typical synthetic strategies that have been used for this purpose, the 
addition of cyanide, of a nitro or of a thiol derivative to an aldehyde, can be mentioned. Ramström and 
co-workers applied this concept to constitutional dynamic chemistry (CDC).
[50]
 This strategy is generally 
based on reversible interconnections between different molecules through (non-)covalent bonds, 
generating dynamic systems primarily under thermodynamic control. If the system is influenced by an 
external factor which preferentially selects one of the components, the dynamic system is forced to re-
equilibrate at the benefit of the selected species. 
Thus, these authors reported the reaction between several aldehydes with acetone cyanohydrin to achieve 
the preparation of all possible cyanohydrin intermediates, which in the presence of immobilized 
Pseudomonas cepacia lipase (PSL-C-I) and an acyl donor, preferentially acylated one of the members of 
the library.
[51]
 In a later study, the reaction between several aldehydes and thiols led to a mixture of 
hemithioacetals which subsequently cyclized selectively by CAL-B-catalyzed intramolecular 
lactonization.
[52]
 Also, the simultaneous reaction of various aldehydes with 2-nitropropane and 1-
butanethiol to achieve a double parallel dynamic system, in which PS-IM preferentially acylated some of 
the intermediates, was developed.
[53]
 As an extension of these studies, the selective formation of a 
lamivudine precursor via dynamic addition–cyclization–acetylation cascade reaction mediated by 
subtilisin Carlsberg starting from two masked aldehydes (Scheme 5a),
[54]
 and the formation of 
enantioenriched 1,3-oxathiolan-5-one derivatives by DKR reaction between an aldehyde and a thiol plus 
intramolecular cyclization catalyzed by CAL-B (Scheme 5b),
[55]
 have recently been demonstrated. 
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Scheme 5. a) Formation of a lamivudine precursor through a dynamic cascade protocol.
[54]
 b) DKR 
process to synthesize 1,3-oxathiolan-5-one derivatives.
[55]
 
 
2.2. DKRs over amino derivatives using hydrolases 
Again, among the different methodologies available to achieve the racemization of amines, the one which 
involves a metal-catalyzed redox process through the imine intermediate is the most commonly 
employed. When combined with a hydrolase-type enzyme, the corresponding enantiopure amides can be 
synthesized. Since Reetz described the metal-based DKR of 1-phenylethylamine using palladium over 
charcoal,
[56]
 different systems such as palladium mixtures, ruthenium, or iridium complexes, and Ni 
Raney have been demonstrated as good racemizing agents of amino derivatives. Due to the formation of 
the imine intermediate, the use of mild conditions is important in order to avoid secondary reactions such 
as hydrolysis into the ketone or dimerization.
[17]
 
Pd-based racemization has widely been used in the last few years (Figure 2). Choi et al. explored the use 
of a Pd nanocatalyst entrapped in an AlO(OH) matrix at 70 ºC together with a PSL-catalyzed KR in THF 
at room temperature in a one-pot sequential manner, in order to deracemize β-phenylalanine amide. Thus, 
after three cycles, the enantiopure (R)-amide was attained in 90% yield.
[57]
 In another example, 
Mexiletine, an antiarrhythmic agent, was resolved into an (R)-amide derivative (71%, 99% ee) via DKR 
using CAL-B and Pd over charcoal in THF at 50 ºC with Et3N as base under 1 atm of H2. This amide was 
further polymerized with CAL-B to get access to a poly(amine-co-ester) bearing mexiletine molecules as 
pendant groups, serving as a potential prodrug candidate.
[58]
 Wu and co-workers recently showed the 
synthesis of enantioenriched (S)-α-trifluoromethylated acetamides combining CAL-B and Pd/Al2O3 as 
racemizing catalyst in toluene at 70 ºC with molecular sieves.
[59]
 In some cases, the addition of an 
exogenous base improved the conversion, i.e. dimethylamine or triethylamine. Depending on the amine 
structure, different selectivities were attained, being especially high for 2,2,2-trifluoro-1-
phenylethylamine (c~ 60-70%, >99% ee). When the reaction was carried out sequentially (KR + 
racemization + KR), better conversions were observed. In a very recent report,
[60]
 the DKR of several 
aromatic amines was performed with CAL-B in toluene at 55 ºC under H2 (0.3 atm), employing a 
Pd/layered double-hydroxide catalyst embedded with a surfactant (dodecyl sulfate anion) to modulate the 
surface acidity and specific surface area of the metal catalyst. Hence, very high conversions (>95%) and 
ee (>90%) were obtained for all tested substrates. 
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Figure 2. Examples of primary amines deracemized via DKR using Pd complexes as racemizing agents. 
Very recently, Bäckvall described the construction of an artificial metalloenzyme by co-immobilizing an 
enzyme and a metal on the same support, a siliceous mesocellular foam (MCF), through covalent 
attachment. The nanometallic component was responsible for the racemization of the amine (Pd
0
), and the 
enzyme (CAL-B) for the KR.
[61]
 (R)-Methoxyacetamide from 1-phenylethylamine was obtained with 
quantitative conversion and selectivity when the reaction was performed in toluene at 70 ºC with Na2CO3 
and molecular sieves under H2 (1 atm). As an extension of this study, the palladium-supported catalyst 
over MCF was combined with two commercially available lipases (CAL-B and PS-C1), allowing the 
DKR process over a series of racemic aromatic amines affording the (R)-amides with high yields (>87%) 
and excellent ee (>97%).
[62]
 This metallic catalyst could be reused up to five times. 
Although less employed, Ru-complexes can also be good candidates for racemizing amines. As a recent 
example, the use of Shvo’s catalyst has been shown to deracemize 1-aryl- and 1-heteroarylpropan-2-
amines with CAL-B in toluene at 100 ºC (yields 50-86%, ee >91%).
[63]
 
Secondary amines have also been resolved under dynamic conditions without the need of metals. Gotor 
and co-workers have described the deracemization of methyl 1,3-dihydro-2H-isoindole-1-carboxylate via 
enzymatic alkoxycarbonylation using PSL-C I in toluene or MTBE at 50-60 ºC (Scheme 6a). Under these 
conditions, the substrate could racemize due to the high acidity of the proton at α-position, obtaining the 
(R)-carbamate in high yields (~70%) and enantioselectivities (90-95%).
[64]
 Liljeblad et al. described the 
DKR of N-tert-butoxycarbonyl-piperazine- and piperidine-2-carboxylic acid methyl esters through lipase-
catalyzed acetylation. In this case, vinyl butanoate was used as acylating agent and the authors proposed 
that the acetaldehyde released in the acylation step could be responsible of the formation of an iminium 
salt (13), that could be deprotonated producing an achiral intermediate that could interconvert both 
enantiomers (Scheme 6b). Thus, using lipase A from Candida antarctica (CAL-A) immobilized on Celite 
in MeCN at 48 ºC, both secondary amines gave rise to the enantiopure (S)-amides in conversions around 
60%.
[65]
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Scheme 6. Examples of DKRs over secondary amines through racemization: a) by an acidic proton 
abstraction;
[64]
 b) by the formation of a Schiff base.
[65]
 
Ramström et al. have recently reported the preparation of a complex dynamic library arising from the 
simultaneous operation of different reversible processes such as imine formation/hydrolysis, 
transimination, hemithioacetal/hemithioaminal formation, and nitroaldol reactions, mixing different 
imines and aldehydes with a thiol and a nitro derivative. As a result, a complex mixture of compounds 
was generated, and in particular, two thiazolidinone compounds coming from an intramolecular acylation 
catalyzed by a lipase (CAL-B), were efficiently amplified.
[66]
 
 
2.3. DKRs over carboxylic acid derivatives 
Using lipases and esterases 
Due to the electron-withdrawing character of carboxylic acid derivatives, the racemization of these 
compounds can be achieved via abstraction of the acidic α-proton. Thus, most of the DKR examples with 
these derivatives when combined with lipase-catalyzed transformations are done under basic conditions. 
Recent examples are the CAL-B-catalyzed transesterification of oxazinones
[67]
 and azlactones
[68]
 using 
Et3N, the hydrolysis of ibuprofen methyl ester employing lipase from Candida rugosa (CRL) at basic 
pH,
[69]
 and the CAL-B-mediated hydrolysis of methyl 2,3-dihydrobenzo[b]furan-3-carboxylate 
derivatives in the presence of a diazaphosphorine base.
[70]
 
Recently, another interesting approach was proposed by Wiggins and Bielawski,
[71]
 who employed 
ultrasonication to racemize poly(methylacrylate) chains with binol as pendant groups (Scheme 7a). 
Hence, hydrolysis catalyzed by cholesterol esterase in a biphasic system composed of methyl isobutyl 
ketone and phosphate buffer (1:1 v/v), was combined with ultrasound pulses to produce the mechanically-
induced isomerization of the unreacted (R)-isomer still attached to the polymer, affording (S)-binol. 
Fox et al. have described the racemization of a cyclopropyl azlactone derivative by a spontaneous 
concerted [3,3]-sigmatropic rearrangement into an achiral dihydrooxepine intermediate (Scheme 7b).
[72]
 
The azlactone was subsequently treated with CAL-B or PSL lipases in MTBE. Under transesterification 
conditions with EtOH, both enantiomers of a precursor of dehydrocoronamic acid, a building block of 
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hepatitis C protease inhibitors, were obtained in excellent yields (>95%) and moderate to excellent ee 
[75% for PSL (1R,2S), 95% for CAL-B (1S,2R)]. 
 
Scheme 7. Hydrolase-catalyzed DKRs to obtain: a) (S)-binol through ultrasound-based racemization;
[71]
 
b) a dehydrocoronamic acid precursor through concerted [3,3]-sigmatropic rearrangement.
[72]
 
 
Using proteases and acylases 
Apart from lipases and esterases, other hydrolases have also been applied to dynamic protocols to 
synthesize valuable carboxylic acid compounds. Servi and co-workers have utilized N-Boc α-amino 
thioesters as starting material to achieve DKR processes through selective hydrolysis, transesterification 
or aminolysis/ammonolysis catalyzed by different subtilisin preparations in the presence of bases.
[73]
 
Trioctylamine was employed as the racemizing agent when the acidity of the α-proton was high (e.g., 
aromatic derivatives), otherwise a stronger base such as 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU) was 
used (e.g., aliphatic derivatives). Thus, the corresponding enantiopure N-Boc α-amino acids, esters or 
amides were attained in excellent yields at 37 ºC and in the presence of different nucleophiles. This 
methodology was further extended to synthesize naphthyl-derived amino acids.
[74]
 
The use of racemases has also been described to perform the substrate racemization although their 
application is still limited due to their narrow substrate specificity and low stability in organic solvents. In 
fact, they are traditionally employed in processes involving amino acids, hydroxy acids and their 
derivatives. Recently, Campopiano and co-workers have mutated an N-acetyl amino acid racemase to 
improve its activity against N-acetyl-allylglycine, thus working at high substrate concentrations (50 g/L), 
and when coupled to a D-acylase, D-allylglycine was obtained in Tris-HCl buffer at 40 ºC in excellent 
yield (89%) and ee (>99%, Scheme 8).
[75]
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Scheme 8. Synthesis of D-allylglycine via DKR combining a racemase and a D-acylase.
[75]
 
 
Using nitrilases and amidases 
Su and co-workers have optimized the synthesis of D-phenylglycine and related derivatives starting from 
the corresponding phenylglycinonitriles, that racemize at basic pH, using a recombinant nitrilase from 
Sphingomonas wittichii RW1.
[76]
 To avoid the decomposition of these substrates, a biphasic medium 
comprised of 1-octanol/buffer (9:1 v/v) was utilized at 25 ºC, obtaining the α-amino acids in high yields 
(60-80%) and ee (90-95%). In a subsequent contribution, a cross-linked preparation of this nitrilase was 
able to achieve the deracemization of N-formyl-phenylglycinonitrile into N-D-formyl-phenylglycine (95% 
yield and 97% ee) in Tris-HCl buffer at 30 ºC. Moreover, this preparation could be recycled up to six 
times.
[77]
 Zheng et al. have reported the synthesis of (R)-o-chloromandelic acid, a precursor of 
Clopidogrel, a platelet aggregation inhibitor, via DKR hydrolyzing o-chloromandelonitrile with whole 
cells of overexpressed nitrilase from Labrenzia aggregata in a biphasic system toluene/phosphate buffer 
(1:9 v/v) at 30 ºC.
[78]
 In this case the racemization proceeded through reversible addition of cyanide to o-
chlorobenzaldehyde. 
Amidases have also been applied to DKR processes. Yasukawa and Asano have showed the use of these 
enzymes coupled to racemases in order to synthesize several phenylalanine derivatives from the 
corresponding racemic phenylalanine amides.
[79]
 Hence, when a mutant from α-amino-ε-caprolactam 
(ACL) racemase was co-expressed with D-amino acid amidase from Ochrobactrum anthropi SV3 in E. 
coli, the corresponding (R)-isomers were attained in high yields (70-80%) and excellent ee (>97%) in 
Tris-HCl buffer and 40 ºC. (S)-Phenylalanine was synthesized (61% yield, >99% ee) from the racemic 
amide precursor by co-expression of ACL racemase and L-amino acid amidase from Brevundimonas 
diminuta in E. coli in phosphate buffer and 40 ºC. Also, the deracemization of 2-amino-3-
phenylpropionitrile into (R)-phenylalanine (95% yield, 90% ee) was performed, using a multienzymatic 
system composed by a purified non-stereoselective nitrile hydratase, together with the previously 
described E. coli co-expressing ACL racemase and D-amino acid amidase (Scheme 9). 
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Scheme 9. Synthesis of (R)-phenylalanine from 2-amino-3-phenylpropionitrile combining a nitrile 
hydratase, a racemase and a D-amino acid amidase.
[79]
 
 
2.4. DKRs over carbonylic derivatives 
It is important to differentiate between the DKR of carboxylic acid derivatives and ketones or aldehydes 
as their reactivity is completely distinct. While for the first ones the biotransformation generally involves 
the interconversion of these species via hydrolysis, (trans)esterification or aminolysis, not creating 
additional chirality, for the second compounds the enzyme usually modifies the carbonyl group into a 
functional moiety, i.e. alcohol or amine, where a new chiral center is generated through a 
desymmetrization redox process. Therefore, in the latter case, it is very common to end up with 
diastereomeric mixtures (Dynamic Desymmetrizations). Obviously, these transformations present a major 
synthetic challenge than the previously mentioned DKR examples, since the enzyme must be both stereo- 
(regarding the prochiral center) and enantio-selective (recognizing the chiral position). 
Using alcohol dehydrogenases (ADHs) 
Similarly, a dynamic process for α-substituted carbonylic derivatives can be carried out under basic 
conditions taking advantage of the acidic character of the α-proton. Hence, the bioreduction over the 
carbonyl moiety using an alcohol dehydrogenase is probably one of the most typical biocatalytic DKR 
systems, being described since 70’s.[6] Recent examples include (Scheme 10a) the reduction of: i) α-
substituted β-keto esters with commercial and overexpressed ADHs,[80,81] ii) α-substituted 1,3-diketones 
using commercial enzymes,
[82]
 iii) α-substituted ketones employing overexpressed ADHs,[83] and iv) α-
substituted aldehydes with an immobilized biocatalyst.
[84]
 In all cases a pH close to neutral was enough to 
develop an efficient racemization of the labile position adjacent to the carbonyl reacting group. 
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Scheme 10. a) Examples of derivatives obtained via bioreduction under dynamic conditions. b) DKR to 
produce α-alkylated carboxylic acids by ADH-catalyzed oxidation of racemic aldehydes.[85] 
Hollmann and co-workers recently showed the synthesis of α-substituted carboxylic acids via ADH-
catalyzed oxidation of the corresponding aldehydes (Scheme 10b). In this case, due to the racemization of 
these substrates at neutral-basic pH, and based on the formation of the aldehyde hydrate, the authors 
envisaged a DKR to synthesize interesting derivatives such as 2-phenylpropionic acid. After enzymatic 
screening and reaction optimization, this compound could be obtained in a mixture of Tris-HCl buffer and 
dimethylsulfoxide (DMSO, 4:1 v/v) at 30 ºC in 90% yield and 88% ee (S), showing that these enzymes 
can still offer uncommon, but advantageous, activities.
[85]
 
Using Baeyer-Villiger monooxygenases (BVMOs) 
In contrast to ADHs, these oxygenases do not induce a novel chiral center as the catalyzed reaction is the 
formation of an ester from the corresponding carbonylic compound. Gotor and co-workers have reported 
the synthesis of acylated α-hydroxy esters and secondary alcohols by DKR with BVMOs starting from α-
substituted β-keto esters and benzylic ketones, respectively (Scheme 11). These oxidoreductases are able 
to perform the selective Baeyer-Villiger oxidation of carbonylic compounds into the corresponding esters. 
In the first case phenylacetone monooxygenase (PAMO) from Thermobifida fusca and 4-
hydroxyacetophenone monooxygenase (HAPMO) from Pseudomonas fluorescens ACB showed the best 
results in terms of conversions (>90%) and selectivities [>99% (S)]. The reactions were achieved in Tris-
HCl buffer with MTBE (5% v/v) at 20-30 ºC.
[86]
 In the second example, a mutant from PAMO was 
employed over a series of racemic ketones in Tris-HCl buffer with MeOH (5% v/v), and in the presence 
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of a basic resin (Lewatit MP62) to facilitate the racemization process at 25 ºC, affording the final products 
with moderate to very high conversions and ee (60-90%).
[87]
 
 
Scheme 11. Production of enantioenriched acylated α-hydroxy acids and secondary alcohols via DKR 
using BVMOs under basic conditions.
[86,87]
 
 
Using transaminases (TAs) 
These biocatalysts are responsible of the transformation of carbonylic derivatives into the corresponding 
amines, therefore TAs have been utilized in dynamic protocols to synthesize enantioenriched amines 
(Figure 3). Thus, a number of relevant amines have been prepared such as α-substituted β-amino esters,[88] 
and a cyclic amino precursor of vernakalant, an antiarrhythmic agent.
[89]
 Very recently, Kroutil and co-
workers have described the amination of a series of α-substituted aromatic aldehydes to obtain chiral 2-
aryl-1-propylamines applying overexpressed TAs in E. coli in phosphate buffer at 30 ºC.
[90]
 
 
Figure 3. Examples of derivatives obtained via enzymatic transaminations under dynamic conditions. 
Peng et al. have developed the synthesis of a smoothened receptor inhibitor, used as target in some 
promising anticancer therapies, where the key step was the transamination of a 2-substituted 4-piperidone 
(last product, Figure 3). In this case the racemization proceeded through an achiral intermediate formed 
by a retro-aza-Michael/aza-Michael addition. Thus, the desired amine was obtained in a very high yield 
(>85%), with excellent diastereo- (>90%) and enantioselectivity (>99%) using a commercial TA in a 
phosphate buffer‒DMSO mixture (4:1 v/v) at 50 ºC.[91] Also, a lactam precursor of niraparib, an 
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anticancer drug, was obtained through amination of a racemic aldehyde that intramolecularly cyclized in a 
cascade fashion.
[92] 
 
3. Stereoinversions 
This technology, which consists in obtaining 100% of one of the substrate enantiomers as the sole product 
by inversion of the other enantiomer (Scheme 1), was traditionally linked to the preparation of optically 
pure alcohols although it has also been extended to the synthesis of enantioenriched amines and amino 
alcohols.
[93]
 In a stereoinversion process, a single enantiomer of the racemate is transformed into an 
achiral intermediate which is then irreversibly transformed into the opposite enantiomer. Thus, this 
methodology represents an attractive approach as a consequence of the availability of the corresponding 
racemates and the ready presence of one enantiomer (half of the final product) in the reaction mixture. 
Stereoinversion processes can be performed by a number of redox biocatalysts whether in purified or 
semipurified form, or as whole-cell biocatalysts. The main difficulty of such processes is finding 
conditions under which two or more (bio)catalysts or chemicals are compatible. 
3.1. Stereoinversions over alcohol derivatives using oxidoreductases 
Traditionally, these bioprocesses have been carried out using whole-cells. In fact, it is true that the 
employment of whole cells has many advantages since they do not require cofactor addition, are easy to 
handle, and no protein purification is needed. However, in some cases, the selectivity of these 
biotransformations cannot be completely controlled since an unknown number of enzymes can be 
potentially active. Thus, the outcome for the targeted transformation can be influenced not only by the 
strain or the substrate structure but also by the cell growth conditions, the presence of metabolites or 
potential inducers. Despite these important disadvantages, this technology has proved to be successful for 
stereoinversion strategies. In these systems, theoretically the enantioselective oxidation of one enantiomer 
affords the prochiral ketone (50%) together with the remaining enantiopure alcohol (50%) in a first 
kinetic resolution; in the second step, the stereoselective reduction of the ketone with a 
stereocomplementary oxidoreductase provides the desired enantiopure alcohol with 100% yield. 
For instances, Metschnikowia koreensis was recently employed for the stereoinversion process of a 
number of aryl secondary alcohols and 1,2-diols.
[94]
 This transformation was stereoselective and consisted 
of the sequential oxidation of the (R)-alcohol and subsequent reduction of the ketone formed to the (S)-
enantiomer in high conversion (>88%) and excellent optical purity (>98%) in aqueous medium at 30 ºC. 
In another recent contribution, the same authors have deracemized a naphthyl alcohol derivative using 
Candida parapsilosis whole cells.
[95]
 It is important to highlight that in general long reaction times are 
required for the deracemization of secondary alcohols when using whole cells, therefore many 
investigations have been focused on overcoming this limitation. Recently, Chadha and co-workers have 
reported whole cell-mediated deracemizations of this type of substrates employing C. parapsilosis ATCC 
7330 in phosphate buffer at 25 ºC.
[96]
 In this work, deracemization of 1-arylethanol derivatives and 4-
phenyl-2-butanol, resulted in the formation of the (R)-enantiomers in excellent optical purity (up to 99% 
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ee) and good yields (up to 78%) at short reaction times (3 h) by tuning the growing conditions. In a 
subsequent work, it was observed that this system preferred deracemizing allylic alcohols with E-
configuration rather than Z.
[97]
 
In some cases whole-cell biotransformations are not successful as the required cofactors are not 
efficiently regenerated in situ. This drawback was investigated and overcome using a recombinant E. coli 
bearing two pyridine nucleotide transhydrogenases PNTs (PntA and PntB), to rebalance the cofactor 
pools in the pathway catalyzed by two carbonyl reductases from Candida parapsilosis (SCR and RCR), 
improving the flux of NAD
+
 (needed by RCR) into NADPH (needed by SCR).
[98]
 In this way, the 
efficient preparation of (S)-1-phenyl-1,2-ethanediol (95% yield, 97% ee) was achieved from the (R)-
alcohol through sequential oxidation/reduction reactions by the stereocomplementary action of SCR and 
RCR (Scheme 12). 
 
Scheme 12. Engineered E. coli harboring RCR, SCR, PntA and PntB for the production of (S)-1-phenyl-
1,2-ethanediol.
[98]
 
In another example, Alcántara and Molinari groups reported the deracemization of benzoins to obtain the 
(S)-enantiomers using Pichia glucozyma yeast.
[99]
 The use of a two-liquid phase system (phosphate buffer 
and n-heptane or isooctane), allowed the preparation of several (S)-benzoins avoiding the formation of the 
corresponding diols, favoring the isolation of the products and improving the enantiomeric excess (up to 
99%).  
An interesting methodology for the efficient one-pot deracemization of aromatic 2-hydroxyacids into the 
(R)-enantiomers (Scheme 13), was achieved combining resting cells of Pseudomonas aeruginosa CCTCC 
M 2011394 and Saccharomyces cerevisiae ZJB5074 with very good conversions (up to 99%) and 
excellent ee (up to 99%) via tandem oxidation and reduction reactions in phosphate buffer at 30 ºC.
[100]
 
The authors also demonstrated the applicability of this biotransformation in a 3-g scale for the synthesis 
of a valuable precursor of an anti-thrombotic drug, Plavix, obtaining the desired (R)-hydroxy acid in 90% 
isolated yield and >99% ee. 
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Scheme 13. Stereoinversion of the 2-hydroxyacid precursor of anti-thrombotic drug Plavix.
[100]
 
The use of purified enzymes has dramatically enhanced the stereocontrol of such stereoinversion 
processes, as additional parameters can now be customized and adjusted to reach the desired outcome. 
Hence, the stereoinversion of secondary alcohols has widely been described using stereocomplementary 
alcohol dehydrogenases, which can selectively catalyze both oxidation and reduction reactions in a 
concurrent manner.
[101]
 A recent case where ADHs were employed in a concurrent manner was reported 
by our group.
[102]
 In this study, lyophilized or resting E. coli cells overexpressing ADH from Rhodococcus 
ruber DSM 44541 (E. coli/ADH-A) were used along with ADH from Lactobacillus brevis (LBADH) for 
the deracemisation of sec-alcohols using 1-phenylethanol as model substrate, obtaining the (R)-alcohol 
with total conversion and >99% ee in aqueous medium at 30 ºC. It is worth noting that no addition of 
cofactor was required for the first oxidative reaction and that the external NADPH-recycling system was 
the driving force of the process. 
Laccases are Cu-dependent oxidases that can be used together with electron mediators, and have shown 
great versatility in organic synthesis. In a recent example, the stereoinversion of a β,β-dihalogenated sec-
alcohol was achieved via one-pot two-step protocol, performing first in a biphasic medium at 20 ºC the 
non-selective oxidation to the ketone intermediate catalyzed by laccase from Trametes versicolor and 
TEMPO, followed by the stereoselective bioreduction catalyzed by overexpressed ADH-A at 30 ºC 
(Scheme 14).
[103]
 The ADH-catalyzed bioreduction determined the ee of the process. Thus, the 
deracemization of 2,2-dichloro-1-phenylethanol was accomplished with excellent conversion and ee 
(>97%). 
 
Scheme 14. Deracemization of 2,2-dichloro-1-phenylethanol using laccase/TEMPO and an alcohol 
dehydrogenase.
[103]
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3.2. Stereoinversions over amino derivatives 
Using two transaminases 
In the last few years, the number of deracemization examples of racemic amines employing two 
enantiocomplementary transaminases through a deamination/amination sequential reaction has increased. 
Ideally, in a first step the enantioselective oxidative deamination leads to the prochiral ketone (50%) 
along with the remaining enantiopure amine (50%); then, in the second step, the stereoselective amination 
of the ketone with a stereocomplementary ω-TA gives access to the final chiral amine in 100% yield. The 
asymmetric synthesis of amines using this tandem protocol is advisable when the racemic amine is more 
accessible than the corresponding ketone, or when such ketone is unstable. Yun and co-workers have 
recently used this approach in a one-pot one-step fashion to deracemize aromatic primary amines, using 
(S)-selective ω-TAs from Polaromonas sp. JS666 [(S)-ω-TAPO] or Vibrio fluvialis JS17 [(S)-TAVF], and 
(R)-selective ω-TAs from Mycobacterium vanbaalenii [(R)-ω-TAMV] or Neosartorya fischeri [(R)-ω-
TANF] (Scheme 15).
[104]
 This method enabled the synthesis of the (R)-antipodes in good conversions (70-
99%) and excellent ee values (up to >99%). The key of this strategy was the use of an amino acceptor (α-
ketoglutaric acid), that was not a good substrate for the second TA. 
 
Scheme 15. Deracemization of racemic primary amines using two stereocomplementary TAs.
[104]
 
 
Using an oxidase and a dehydrogenase 
The feasibility of multienzymatic networks involving oxidases and dehydrogenases has efficiently 
afforded optically pure amino acids starting from the corresponding racemates. Patel et al. have applied 
this methodology to the synthesis of a key intermediate of a type II diabetes drug [(S)-14].
[105]
 First, a 
recombinant amino acid oxidase from Trigonopsis variabilis provided the enantioselective oxidation of 
the (R)-amino acid leaving the (S)-antipode intact (Scheme 16a). Then, this keto acid was transformed 
into the desired (S)-amino acid by means of a reductive amination using whole cells from Sporosarcina 
ureae SC16048 containing an (S)-amino acid dehydrogenase. The reaction was carried out at 1.95-g scale 
in aqueous medium at 28 ºC yielding (S)-14 in 54% overall yield and >99% ee. A two-step protocol was 
needed since the oxidase was otherwise inhibited. 
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Scheme 16. Deracemization strategy of an amino acid combining: a) an amino acid oxidase and an amino 
acid dehydrogenase; b) an amino acid oxidase and a transaminase.
[105]
 
 
Using an oxidase and a TA 
Another related deracemization approach for the production of (S)-14 was based on the amino group 
oxidation to the corresponding keto derivative intermediate using the recombinant (R)-amino acid oxidase 
from T. variabilis, which was further aminated by a recombinant (S)-transaminase from Burkholderia sp. 
(Scheme 16b).
[105]
 Using this strategy, the one-pot biotransformation could be done in buffer at 30 ºC. The 
applicability of this multienzymatic approach was shown by scaling up this bioprocess at 607 g of the 
racemic amino acid to obtain the enantiopure (S)-amino acid in 66% yield and >99% ee. 
In another study, a non-proteinogenic amino acid such as L-homoalanine was employed as a model 
substrate in a similar approach. D-Amino oxidase from Rhodotorula gracilis (DAAO), a FAD dependent 
enzyme, was fused to Vitreoscilla hemoglobin (VHb) to form VHb-DAAO.
[106]
 This protein improved the 
activity and stability of DAAO, and achieved the stereospecific oxidation of D-homoalanine to the 
corresponding imine, which was further hydrolyzed to form the keto acid intermediate. This 
biotransformation was then combined with V. fluvialis JS17 transaminase using benzylamine as the amino 
donor to obtain L-homoalanine. To avoid product inhibition, a biphasic system was necessary boosting 
the conversion of the process (97%, ee >99%). 
 
4. Cyclic deracemizations 
Cyclic deracemization systems traditionally differ from stereoinversions in the use of a non-selective 
irreversible reaction combined with a second selective transformation that accumulates the enantiomer 
which is not transformed (Scheme 1). Hence, a typical deracemization example consists of a selective 
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enzyme-catalyzed oxidation into a prochiral intermediate, which is then reduced back via non-selective 
chemical reduction process.
[107]
 Therefore, depending on the selectivity of the enzyme, after a certain 
number of cycles an enantiopure product can be reached. 
4.1. Cyclic deracemizations over alcohol derivatives 
In these processes, the enzymatic selective step can be performed with isolated enzymes or whole-cell 
biocatalysts. As a recent example, Kurina-Sanz et al. used undifferentiated plant cells from Gardenia 
jaminoides to deracemize 1-phenylethanol and other sec-alcohol derivatives.
[108]
 This biocatalyst could 
oxidize the (S)-enantiomer from the racemic mixture leaving the other enantiomer untouched in a kinetic 
resolution. Then, NaBH4 was added for the reduction of the corresponding ketone. Although the activity 
of the cells was clearly affected by the reducing agent, when entrapping the biocatalyst in calcium 
alginate this strategy could be expanded to a series of secondary alcohols, and after several cycles the 
corresponding (R)-alcohols could be prepared in yields >82% and 71-97% ee. 
4.2. Cyclic deracemizations over amino derivatives 
Using an amino oxidase and a non-selective chemical reducing agent 
Another approach to obtain enantiopure amines is based on the combination of an amino oxidase with a 
chemical reagent. The enzyme performs the enantioselective oxidation of the racemic amine to afford the 
corresponding imine or iminium ion (depending on the substrate) coupled to a non-selective reducing 
agent, obtaining back the enantioenriched starting material. After several rounds, the accumulation of one 
enantiomer of the amine can be successfully realized. Recently, recombinant cells of E. coli 
overexpressing cyclohexylamine oxidase (CHAO) from Brevibacterium oxydans IH-35A, in combination 
with the borane-ammonia complex, were applied by Lau and co-workers to deracemize several primary 
amines into the corresponding (R)-enantiomers with moderate yields (62-75%) and excellent ee (>97%) 
in phosphate buffer at 30 ºC.
[109]
 In a later report, the same authors improved the performance of this 
biocatalyst by rational design. Five single-point mutants were prepared and tested in the same process, 
finding that the activity of some mutants was enhanced.
[110]
 A variant was used in the deracemization of 
1-aminotetraline, precursor of Norsertraline, a selective serotonin reuptake inhibitor, yielding (R)-1-
aminotetraline in 76% and >99% ee (Scheme 17). Recently, this strategy was extended to a secondary 
amine.
[111]
 Thus, the deracemization of 2-methyl-1,2,3,4-tetrahydroquinoline was achieved with a new 
discovered mutant of CHAO giving access to the (R)-amine in 76% yield and >97% ee. 
 
Scheme 17. Cyclic deracemization applied to the synthesis of a precursor of Norsertraline.
[110]
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In recent years, evolved variants of monoamine oxidase N from Aspergillus niger (MAO-N) have found 
new applications in the preparation of enantiopure amines. In one elegant example, Turner and co-
workers designed a biometallic whole cell catalyst composed of E coli BL21 cells overexpressing a 
monoamine oxidase (MAO-N-D5) with Pd(0) nanoparticles on the outer membrane.
[112]
 This 
biocomposite was used for the deracemization of 1-methyltetrahydroisoquinoline (MTQ) to (R)-MTQ 
through the imine intermediate with an ee of up to 96%, using H2 as electron donor for the reduction step 
in a sequential one-pot cyclic manner. This study illustrated the potential of combining the rapidly 
evolving synthetic biology techniques with novel nanometallic catalysts in a single organism for multistep 
transformations. 
Although important developments have been made in the field, only recently new evolved enzymes have 
been found for sterically demanding molecules. Hence, the potential for using MAO-N variants was 
proved for the preparation of valuable biologically active molecules such as alkaloid crispine A. Initially, 
this approach with MAO-N-5 presented several limitations such as long reaction times (40 h) and low 
yields (48%). In an attempt to improve this deracemization, several variants of MAO-N were 
prepared.
[113]
 After modelling crispine into the active site of MAO-N-5, four residues were highlighted as 
hot spots. Thus, the synthesis of (R)-crispine A was achieved in 2 h with an ee of >97% by using the 
MAO-N-9C variant, whose specific activity was 990-fold higher than MAO-N-5, together with the 
ammonia-borane complex as reducing agent in phosphate buffer at 37 ºC. In another example, the 
asymmetric synthesis of several bioactive natural products such as Eleagnine, an alkaloid isolated from 
Chrysophyllum albidum and Leptaflorin, a psychedelic agent, was successfully performed using MAO-N-
D9.
[114]
 Furthermore, the development of a new D11 variant, which possessed high activity and excellent 
stereoselectivity toward bulky substrates, was accomplished. This enzyme was applied to the 
deracemization of Solefenacin, a competitive muscarinic acetylcholine receptor antagonist, and several 
Levocetirizine precursors, an antihistamine drug, thus expanding the substrate scope of MAO-N. For 
instance, the deracemization of 4-chlorobenzhydrylamine for the production of the (R)-configured amine 
was carried out with excellent enantiomeric excess (97%) and moderate isolated yield (45%, Scheme 
18a). Also, the deracemization of several β-carbolines was achieved with MAO-N-D10 or MAO-N-D11, 
observing a strong influence on the enzyme stereoselectivity depending on the substitution pattern at 
position 1 (Scheme 18b).
[115]
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Scheme 18. a) Deracemization of a Levocitirizine motif using a MAO variant and the ammonia-borane 
complex.
[114]
 b) Deracemization of β-carbolines using MAO-N-D10 and MAO-N-D11.[115] 
 
Using new strategies 
Novel methods for the transformation of a racemic amine into an enantiopure product have been 
developed in the last few years by combining different (bio)catalysts in more complex systems. Inspired 
by synthetic and concurrent cascades, the cyclic deracemization of different amines was successfully 
achieved using a metalloenzyme, based on the supramolecular entrapment of an iridium complex within 
streptavidin acting as an artificial transfer hydrogenase (ATHase), together with a monoamino oxidase 
and a catalase (to quench the poisoning H2O2). A formate salt was added for regeneration.
[116]
 Thus, cyclic 
deracemization of secondary amines such as 1-methyltetrahydroisoquinoline or 2-cyclohexylpyrrolidine 
into the corresponding (R)-amines was investigated, achieving excellent conversions (99%) and ee (99%). 
In light of these results, authors demonstrated that these three enzymes could work cooperatively to 
prepare enantiopure amines in an orthogonal redox cascade. This approach holds promise for future 
applications in biosynthetic cascades. 
In a recent example described by Turner and Kroutil groups, the deracemization of various 
benzylisoquinolines into the (S)-enantiomers, combining MAO-N D11 variant and the ammonia-borane 
complex, was performed in aqueous medium at 37 ºC.
[117]
 As a further extension of this methodology, this 
biocatalyst was combined with a reductant agent (morpholine·BH3 complex) and the berberine bridge 
enzyme (BBE) to yield (S)-berbines.
[118]
 BBE is a selective oxidase which catalyzes the intramolecular C-
C coupling of (S)-reticuline leading to (S)-scoulerine. Only recently the substrate scope of BBE was 
studied, being suitable for the KR of these types of substrates.
[119]
 The deracemization of a series of 
benzylisoquinolines was achieved by simultaneous cyclic deracemization using the MAO/borane system 
coupled to a kinetic oxidative resolution catalyzed by BBE (Scheme 19). This three-step approach led to 
conversions up to 97% and excellent enantiopurities (ee >97%) into the (S)-berbines. Moreover, the 
applicability of this system was demonstrated at preparative scale (150-165 mg) with similar results. This 
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approach shows that challenging synthetic routes can be reconsidered into other more efficient and 
sustainable. 
 
Scheme 19. Deracemization of a series of benzylisoquinolines into the corresponding (S)-berbines using 
MAO and BBE.
[118]
 
 
Using an amino acid oxidase and a non-selective chemical reducing agent 
Patel’s group also reported a cyclic deracemization route for the preparation of the previously mentioned 
amino acid 14.
[105]
 In this case, (R)-amino acid oxidase from Trigonopsis variabilis immobilized on Celite 
was combined with a chemical reductant (ammonia-borane complex) for the reduction of the imine 
intermediate. This cyclic deracemization was possible as the reduction of the imine intermediate was 
quicker than its hydrolysis. The final (S)-amino acid was obtained with a yield of 79% and >99% ee. 
Nowadays, there is a need for novel biocatalysts to cover new reactions or improve existing activities. In 
this sense, enzyme evolution to create new catalysts with desired functions is becoming an important tool 
in the last years. For example, an (R)-amino oxidase has recently been redesigned starting from porcine 
kidney D-amino acid oxidase (pkDAO).
[120]
 The engineered enzyme obtained by directed evolution, 
showed a high R-specificity towards benzylic substrates and was further applied to the deracemization of 
α-methylbenzylamine in the presence of NaBH4, transformation that had not been previously described 
for amino acid oxidases. This work opens the door for future applications in the synthesis of chiral and 
more complex amines via deracemization. 
 
4.3. Cyclic deracemizations over sulfoxide derivatives using oxidoreductases 
Parvulescu and co-workers reported the deracemization of sulfoxides by combining E. coli cells, which 
performed the selective reduction of these compounds into the sulfides, followed by a non-selective 
oxidation with a heterogeneous catalyst (Ta2O5-SiO2).
[121]
 In this case, due to incompatibility of both 
reactions, they were performed in a sequential manner. For instance, after three cycles, (S)-methyl p-tolyl 
sulfoxide was prepared in 56% yield and 98% ee (Scheme 20). 
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Scheme 20. Sequential deracemization of methyl p-tolyl sulfoxide via enzymatic reduction plus metal-
catalyzed oxidation.
[121]
 
 
5. Enantioconvergent processes 
These strategies involve transformations in which both enantiomers of a racemic mixture are converted 
into the same enantiomer of a product or a homochiral mixture of products through different reaction 
pathways, one via retention of configuration and the second one through inversion of configuration 
(Scheme 1).
[122]
 Therefore for this strategy an inverting enzyme can be used. There are some biocatalysts 
capable to perform this transformation: glycosidases, haloalkane dehalogenases, epoxide hydrolases and 
alkylsulfatases. 
Using haloalkane dehalogenases 
Janssen and Feringa groups described a chemoenzymatic enantioconvergent process for the synthesis of 
enantiopure α-substituted amides using haloalkane dehalogenases.[123] In this study, α-bromoamides 
reacted with high enantioselectivity in the presence of haloalkane dehalogenase from Bradyrhizobium 
japonicum USDA110 (DbjA), affording a homochiral mixture consisting of the remaining (S)-brominated 
substrate enantiomer and the (S)-alcohol product coming from the inverting reaction over the (R)-
enantiomer (Scheme 21). Then, after mesylation, the α-bromide and the α-mesyloxy amides were finally 
treated with several nucleophiles in a SN2 process to achieve the substituted (R)-amides. These products 
were obtained in high yields (up to 96% after the three steps) and excellent ee (up to 98%). 
 
Scheme 21. Enantioconvergent strategy for the preparation of enantiopure α-substituted amides using 
haloalkane dehalogenases in the inverting step.
[123]
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Using alkylsulfatases 
Other stereoselective inverting enzymes are alkylsulfatases, which have been identified as member of the 
β-metallolactamase family and that catalyze the nucleophilic displacement of HSO4
‒
 by water via 
OH
‒
.
[124]
 Among them, Pseudomonas sp. DSM 6611 alkylsulfatase (Pisa1) has widely been used in the 
deracemization of sec-alcohols. In an interesting report from Faber’s group, this enzyme was 
overexpressed in E. coli and used for the preparation of alkyl-alkyl (S)-configured sec-alcohols together 
with the non-reacting (S)-sulfate esters. The latter can be then transformed into the (S)-alcohols by 
chemical deprotection under acidic conditions.
[125]
 In a later study, the same authors investigated the 
scope of this enzyme finding that it showed good stereoselectivity in the hydrolysis of a variety of sulfate 
esters such as aromatic, olefinic and acetylenic sulfates, especially when bearing two groups of different 
size. Moreover, the addition of DMSO (20% v/v) proved to be very convenient in order to obtain better 
enantioselectivities.
[126]
 This enzyme was also employed to successfully deracemize hex-5-en-2-ol into 
the (S)-enantiomer, precursor of a lasiodiplodin derivative, which displays antileukemia activity.
[127]
 
Recently, an elegant report for the one-pot deracemization of various sec-alcohols was described in the 
presence of two stereocomplementary sulfatases (Scheme 22).
[128]
 This study was possible due to the 
combination of the retaining and inverting features of two sulfatases by sequential or simultaneous 
enantioconvergent hydrolysis of the corresponding sulfate esters. The key of this approach was the 
stereochemical properties of arylsulfatase from Pseudomonas aeruginosa (PAS), an R-selective enzyme 
working with retention of configuration, and the S-preference showed by Pisa1 with inversion of 
configuration. Using this protocol, the deracemization of sulfate esters to form the corresponding 
unprotected (R)-alcohols could be achieved with conversions higher than 80% and ee higher than 90%. 
 
Scheme 22. One-pot deracemization of sec-alcohols using simultaneously two stereocomplementary 
alkylsulfatases.
[128]
 
 
Using epoxide hydrolases 
This class of enzymes has been used in enantioconvergent processes for the preparation of enantiopure 
diols in a theoretical yield of 100% starting from the corresponding racemic epoxides. This is possible if 
one of the enantiomers reacts with retention of configuration, while the other one is hydrolyzed with 
inversion. Kotik et al. evolved the epoxide hydrolase (EH) from Aspergillus niger M200 by saturation 
mutagenesis.
[129]
 This was performed at nine sites close to the binding pocket and the substrate access 
tunnel. The final EH mutant was capable to transform racemic styrene oxide and p-chlorostyrene oxide to 
the corresponding (R)-diols with an ee of 70% for both substrates. In an attempt to enhance the products 
ee, a sequential bi-enzymatic reaction was performed combining the wild-type enzyme and several 
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evolved mutants, observing a significant increase of the ee values from 70% to 88-91%. In a subsequent 
work, Kau2 EH retrieved from the genomic DNA of a microbial community, was also mutated for the 
selective enantioconvergent hydrolysis of p-chlorostyrene oxide into the (R)-diol, finding a variant that 
improved the selectivity of this transformation up to 93% ee.
[130]
 The preparation of these compounds 
(Scheme 23) was also achieved by a sequential reaction using recombinant E. coli cells overexpressing 
two regio- and enantiocomplementary EHs, namely Caulobacter crescentus (CcEH) and Mugil cephalus 
(McEH), obtaining (R)-1-phenyl-1,2-ethanediol in 95% yield and 90% ee.
[131]
 
 
Scheme 23. Strategy for the preparation of enantiopure (R)-1,2-phenylethanediol using two 
enantiocomplementary epoxide hydrolases.
[131]
 
 
Using lipases 
The stereoconvergence of a racemate into a single enantiopure product can also be achieved through a 
sequential transformation performing a lipase-catalyzed resolution followed by a chemical inversion of 
the remaining or formed alcohol by, i.e. a Mitsunobu reaction. Matsumoto and co-workers reported the 
deracemization of acetylated 1,2-diols O-tosylated at β-position combining a lipase-catalyzed hydrolysis 
and a Mitsunobu reaction.
[132]
 The authors examined the hydrolysis of these bulky substrates catalyzed by 
PS lipase, and made use of immobilized triphenylphospine in polystyrene for the Mitsunobu inversion. 
Using this protocol, (S)-2-acetoxy-6-benzyloxytosylate 15, key core of alkaloid (S)-coniine, was 
synthesized in very good overall yield (82%) and 98% ee (Scheme 24). In another example, secondary 
benzylic acetates were deracemized employing a two-step protocol consisting of a CAL-B-catalyzed 
hydrolysis followed by a Mitsunobu reaction obtaining the (S)-acetates in high yields (70-89%) and 
moderate to excellent ee (57-99%).
[133]
 
 
 
Scheme 24. Preparation of (S)-15, key intermediate of (S)-coniine, via lipase-catalyzed hydrolysis plus 
Mitsunobu inverting protocol.
[132]
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6. Summary and Outlook 
Since 80s biocatalyzed kinetic resolutions of racemates have been systematically studied to obtain 
compounds in enantiopure form. This is a well-established methodology as a great number of biocatalysts 
are easily available. Unfortunately, in these processes 50% of the starting material must be discarded 
unless the opposite antipode is also of interest. Therefore, in order to complete the job, yields close to 
100% are highly desired to obtain optically pure products. To achieve this purpose, different techniques 
have been developed to overcome the yield limitation imposed by KRs. Among the methods that are 
already implemented at both academic and industrial level, dynamic kinetic resolutions, deracemizations 
via stereoinversion, cyclic deracemizations and enantioconvergent processes can be mentioned. DKRs are 
well-implemented protocols and those operating with a metal-catalyst as racemizing agent, are the most 
used to deracemize alcohols or amines coupled to a hydrolase. While for the first ones Ru catalysts have 
been the most commonly employed, for amino compounds palladium-based systems are usually 
exploited. In the case of DKRs over carboxylic or carbonylic derivatives, due to the high acidity 
displayed by the proton at α-position, a good choice is the application of basic conditions to racemize 
these compounds. Nowadays the modification of enzymes through molecular engineering and the 
application of very promising biocatalysts such transaminases are providing novel efficient protocols. 
Also, the design of new metal catalysts or metal‒enzyme composites is allowing the access to highly 
valuable compounds. 
In the case of stereoinversions, these systems are more usual when working with oxidoreductases to 
deracemize alcohols or amines, but recently transaminases have also been utilized. In this case whole cell 
systems or two stereoselective and enantiocomplementary biocatalysts must be selected. If one of the 
processes is not selective, still deracemization can be attained in a cyclic manner. Good examples of this 
methodology are amino oxidases coupled to a non-selective chemical reagent, but also very recently the 
employment of metalloenzymes with hydrogen transfer activity has been envisaged as a potential 
alternative to these protocols. Enantioconvergent systems are probably the less developed deracemization 
techniques but still they can find interesting applications when using inverting enzymes such 
dehalogenases, epoxide hydrolases and alkylsulfatases in order to obtain, e.g. chiral alcohol or diol 
derivatives. 
As a result of the tremendous advances in the biocatalysis field especially due to protein engineering, 
DNA sequencing and computational design, impressive novel capabilities can be conferred to enzymes. 
Obviously, these redesigned biocatalysts can be successfully implemented in deracemization protocols to 
access challenging targets, e.g. sterically demanding, in excellent yields and enantioselectivities. 
Moreover, the need for more sustainable processes based on highly efficient transformations, is turning 
the attention into the development of systems where the combination of several (bio)catalytic steps can be 
performed in one-pot, designing multi-step catalytic cascade or tandem processes avoiding the isolation 
of the corresponding intermediates. Accordingly, the understanding of enzymatic mechanisms, 
improvements in the enzyme stability, and the combination of several (bio)catalysts in one-pot or 
stepwise fashion is allowing in many cases a dramatic progress in chemical synthesis and will help 
biocatalysts to spread into industry. 
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